Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-012325
Filing Date
2022-03-30
Accepted
2022-03-30 08:09:24
Documents
116
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ortx-10k_20211231.htm   iXBRL 10-K 4456666
2 EX-10.19 ortx-ex1019_562.htm EX-10.19 62852
3 EX-21.1 ortx-ex211_7.htm EX-21.1 11061
4 EX-23.1 ortx-ex231_6.htm EX-23.1 2707
5 EX-31.1 ortx-ex311_8.htm EX-31.1 19357
6 EX-31.2 ortx-ex312_10.htm EX-31.2 19007
7 EX-32.1 ortx-ex321_9.htm EX-32.1 8023
8 EX-32.2 ortx-ex322_11.htm EX-32.2 8225
9 GRAPHIC geajuovwk5do000002.jpg GRAPHIC 114137
10 GRAPHIC geajuovwk5do000001.jpg GRAPHIC 415820
  Complete submission text file 0001564590-22-012325.txt   17369158

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA ortx-20211231.xsd EX-101.SCH 107165
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20211231_cal.xml EX-101.CAL 116400
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20211231_def.xml EX-101.DEF 307059
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20211231_lab.xml EX-101.LAB 752238
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20211231_pre.xml EX-101.PRE 590051
110 EXTRACTED XBRL INSTANCE DOCUMENT ortx-10k_20211231_htm.xml XML 2958256
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38722 | Film No.: 22783237
SIC: 2836 Biological Products, (No Diagnostic Substances)